Difficulties of differential diagnosis in multisystem atrophy
https://doi.org/10.30629/2658-7947-2019-24-6-39-46
Abstract
Multiple systemic atrophy.(MSA) is a progressive neurodegenerative disease with a poor prognosis and unknown etiology, which belongs to the “atypical parkinsonism” group of diseases. Currently, the diagnosis of MSA is difficult and at the present stage remains predominantly clinical. But, despite the fact that no effective treatment has been developed, timely diagnosis and symptomatic therapy can improve the patient’s quality of life. The article presents a clinical observation of a patient with MSA, a feature of which was the combination of MSA with vascular pathology, which greatly complicated and delayed the diagnosis of MSA.
About the Authors
M. P. Topuzova
Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Mariya P. Topuzova - MD, PhD, Associate Professor of the Department of Neurology and Psychiatry, Senior Researcher of the Research Laboratory of Cerebrovascular Pathology of the Research Department of Neurology and Neurorehabilitation, V.A. Almazov Federal National Medical Research Centre.
197341, Akkuratova street 2, Saint-Petersburg.
T. M. Alekseeva
Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
197341, Akkuratova street 2, Saint-Petersburg.
А. F. Zhiryakov
Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
197341, Akkuratova street 2, Saint-Petersburg.
T. A. Pavlova
Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
197341, Akkuratova street 2, Saint-Petersburg.
References
1. Levin O.S., Fedorova N.V., eds. Parkinson’s disease [Bolezn’ Parkinsona]. 2rd ed..M.: MEDpress-inform; 2012. 352 p. (in Russian).
2. Levin O.S. Atypical parkinsonism: clinical and neuroimaging aspects of differential diagnosis. Al’manakh klinicheskoy meditsiny. 2001;4:73–7. (in Russian).
3. Ershova M.V., Akhmadullina D.R., Fedotova E. Yu., Illarioshkin S.N. Modern submission about multiple system atrophy. Aktual’nyevoprosynevrologii. 2018;4:3–13. (in Russian).
4. Quinn N. A short clinical history of multiple system atrophy. Clin Auton Res. 2015Feb;25(1):3–7. doi: 10.1007/s10286-014-0265-7.
5. Elkin M.N. Multiple systemic atrophy. Nevrologicheskiy zhurnal. 1997;2(6):46–51. (in Russian).
6. Mitsui J., Matsukawa T., Ishiura H., Fukuda Y., Ichikawa Y., Date H. et all. (Multiple-System Atrophy Research Collaboration). Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013Jul;18;369(3):233–244. doi: 10.1056/NEJMoa1212115
7. Quinn N.P. How to diagnose Multiple System Atrophy. Movement Disorders. 2005;20(12);5–10.
8. Dickson D.W., Lin W., Liu W.K., Yen S.H. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol. 1999Oct;9(4):721–32.
9. Wenning G..K., Tison F., Ben Shlomo Y., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. MovDisord. 1997Mar;12(2):133–47. doi: 10.1002/mds.870120203
10. Yakhno N.N., eds. Diseases of the nervous system: a guide for doctors. [Bolezni nervnoy sistemy: Rukovodstvo dlya vrachey]. 4d ed. M.: Meditsina; 2005;2:512. (in Russian).
11. Quinn N., Marsden C.D., Fahn S. et all. Multiple system atrophy. Movement Disorders. 1994;3:262–82.
12. Colosimo C., Morgante L., Antonini A., Barone P., Avarello T.P., Bottacchi E. et al. (PRIAMO STUDY GROUP). Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol. 2010;257(1):5–14. doi: 10.1007/s00415-009-5255-7
13. Gilman S. Parkinsonian syndromes. Clin Geriatr Med. 2006 Nov;22(4):827–42. doi:10.1016/j.cger.2006.06.007
14. Konagaya M., Konagaya Y., Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1528–31. doi:10.1136/jnnp.57.12.1528
15. Brooks D.J., Seppi K. (Neuroimaging Working Group on MSA). Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord. 2009 May 15;24(7):949–64. doi: 10.1002/mds.22413
16. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008Aug;26;71(9):670–76. doi: 10.1212/01.wnl.0000324625.00404.15
17. Levin O.S., Dokadina L.V. Epidemiology of parkinsonism and Parkinson’s disease. Nevrologicheskiy zhurnal. 2005;(5):41–9. (in Russian)].
18. Kicherova O.A., Reykhter L.I. Modern ideas about multiple system atrophy (literature review). MeditsinskoeobrazovanieUrala. 2018;3:154–57. (in Russian).
19. Wenning G.K., Ben Shlomo Y., Magalhães M., Daniel S.E., Quinn N.P. Clinical features and natural history of multiple system atrophy. Ananalysis of 100 cases. C Brain. 1994:835–45. doi: 10.1093/brain/117.4.835
20. Schrag A., Wenning G.K., Quinn N., Ben-Shlomo Y. Survival in multiple system atrophy. Mov Disord. 2008;23(2):294–6. doi: 10.1002/mds.21839
21. Petrovic I.N., Ling H., Asi Y., Ahmed Z., Kukkle P.L., Hazrati LN. et al. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord. 2012):1186–90. doi: 10.1002/mds.25115
22. Winikates J., Jankovic J. Clinical correlates of vascular parkinsonism. ArchNeurol. 1999 Jan;56(1):98–102.
23. Kalra S., Grosset D.G,.,Benamer H.T. Differentiating vascular parkinsonism from idiopathic Parkinson’s disease: a systematic review. Mov Disord. 2010;25(2):149–56. doi: 10.1002/mds.22937
Review
For citations:
Topuzova M.P., Alekseeva T.M., Zhiryakov А.F., Pavlova T.A. Difficulties of differential diagnosis in multisystem atrophy. Russian neurological journal. 2019;24(6):39-46. (In Russ.) https://doi.org/10.30629/2658-7947-2019-24-6-39-46
Views:
1492
Email this article 